Based on these data, we suggest that significantly increased expression of both PPBP and DEFA1/DEFA3 and their encoded proteins has the potential to be established as a synergistic predictive biomarker for CHD risk in hyperlipidaemia patients. Here, DEFA3 is linked to coronary artery disorder.